Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ariel B Bourla

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 28, 2020
Real-World Data as an Evidence Source in Nuclear MedicineAriel B Bourla, Ken Herrmann
Digital Health|December 6, 2021
Bridging the divide between clinical research and clinical care in oncology: An integrated real-world evidence generation platformAriel B Bourla, Neal J Meropol
Pharmacoepidemiology and Drug Safety|July 6, 2021
Differential frequency in imaging-based outcome measurement: Bias in real-world oncology comparative-effectiveness studiesBlythe J S Adamson, Xinran Ma, Sandra D Griffith, et al.
Advances in Therapy|April 17, 2022
Analysis of a Real-World Progression Variable and Related Endpoints for Patients with Five Different Cancer TypesAracelis Z Torres, Nathan C Nussbaum, Christina M Parrinello, et al.
JTO Clinical and Research Reports|September 12, 2022
Complementary Roles for Tissue- and Blood-Based Comprehensive Genomic Profiling for Detection of Actionable Driver Alterations in Advanced NSCLCLee S Schwartzberg, Gerald Li, Khaled Tolba, et al.
JCO Clinical Cancer Informatics|August 13, 2019
Characterizing the Feasibility and Performance of Real-World Tumor Progression End Points and Their Association With Overall Survival in a Large Advanced Non-Small-Cell Lung Cancer Data SetSandra D Griffith, Rebecca A Miksad, Geoff Calkins, et al.
Contemporary Clinical Trials Communications|March 3, 2025
Real-world enrollment for a prospective clinico-genomic database using a pragmatic technology-enabled platformAlexia Exarchos, Ariel B Bourla, Maneet Kaur, et al.
JCO Precision Oncology|January 31, 2025
Digital Pathology-Based Multimodal Artificial Intelligence Scores and Outcomes in a Randomized Phase III Trial in Men With Nonmetastatic Castration-Resistant Prostate CancerFelix Y Feng, Matthew R Smith, Fred Saad, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 28, 2020
Real-World Data as an Evidence Source in Nuclear MedicineAriel B Bourla, Ken Herrmann
Digital Health|December 6, 2021
Bridging the divide between clinical research and clinical care in oncology: An integrated real-world evidence generation platformAriel B Bourla, Neal J Meropol
Pharmacoepidemiology and Drug Safety|July 6, 2021
Differential frequency in imaging-based outcome measurement: Bias in real-world oncology comparative-effectiveness studiesBlythe J S Adamson, Xinran Ma, Sandra D Griffith, et al.
Advances in Therapy|April 17, 2022
Analysis of a Real-World Progression Variable and Related Endpoints for Patients with Five Different Cancer TypesAracelis Z Torres, Nathan C Nussbaum, Christina M Parrinello, et al.
JTO Clinical and Research Reports|September 12, 2022
Complementary Roles for Tissue- and Blood-Based Comprehensive Genomic Profiling for Detection of Actionable Driver Alterations in Advanced NSCLCLee S Schwartzberg, Gerald Li, Khaled Tolba, et al.
JCO Clinical Cancer Informatics|August 13, 2019
Characterizing the Feasibility and Performance of Real-World Tumor Progression End Points and Their Association With Overall Survival in a Large Advanced Non-Small-Cell Lung Cancer Data SetSandra D Griffith, Rebecca A Miksad, Geoff Calkins, et al.
Contemporary Clinical Trials Communications|March 3, 2025
Real-world enrollment for a prospective clinico-genomic database using a pragmatic technology-enabled platformAlexia Exarchos, Ariel B Bourla, Maneet Kaur, et al.
JCO Precision Oncology|January 31, 2025
Digital Pathology-Based Multimodal Artificial Intelligence Scores and Outcomes in a Randomized Phase III Trial in Men With Nonmetastatic Castration-Resistant Prostate CancerFelix Y Feng, Matthew R Smith, Fred Saad, et al.
Pageof 1